Policy / Pricing Medicare obesity drug pilot extended after insurer pushback PharmaphorumMedicare will cover the cost of a pilot of weight-loss drug coverage, after health insurers refuse to take part.Policy / PricingMetabolic & GLP-1Read full story pharminent April 22, 2026 (Last updated: April 22, 2026) Pharmaphorum Medicare will cover the cost of a pilot of weight-loss drug coverage, after health insurers refuse to take part. Policy / PricingMetabolic & GLP-1Read full story Post navigation Previous: Health Canada approves Biocon’s two denosumab biosimilarsNext: BioAegis and Prenosis partner for inflammatory disease therapies Related Stories Policy / Pricing MFN affecting Swiss medicines access, says Interpharma pharminent August 13, 2026 Policy / Pricing Prior Authorization Metrics Provide New Insights into Insurer Practices, but Gaps Remain pharminent August 13, 2026 Policy / Pricing Trump signs order that nearly halves childhood immunisation coverage pharminent August 11, 2026
